Connor, Clark & Lunn Investment Management (CC&L)’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$54.5K Buy
2022
Q3
Sell
2022
Q2
$526K Buy